China NMPA Product Recall - Digital medical X-ray imaging system

Suzhou Fujifilm Imaging Equipment Co., Ltd. initiated a voluntary Class III recall of its Digital Medical X-ray Imaging Systems (Registration No.: Su Xie Zhu Zhun 20152300234), announced on May 16, 2017. This action was taken under the regulatory oversight of China's National Medical Products Administration (NMPA). The primary reason for the recall stemmed from the company's failure to organize production in a timely manner, which was required after a registration change for the medical device. This operational lapse meant that production did not adhere to the updated regulatory requirements, necessitating the recall of the affected units to ensure compliance and product safety. As a required action, the company conducted a voluntary Class III recall, indicating a commitment to rectifying the identified issue. Further details regarding the specific models, specifications, and batch numbers involved are documented in the official Medical Device Recall Event Report Form. This incident underscores the critical importance of strictly adhering to production protocols and promptly incorporating regulatory updates following product registration changes within the medical device manufacturing sector.